Graham W Slack Selected Research

Prednisone (Sone)

1/2017	Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.
1/2017	Genetic polymorphism at BCL2 as a predictor for rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone efficacy in patients with diffuse large B-cell lymphoma.
9/2015	Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies.
8/2015	The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association.
12/2014	CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia.
10/2012	Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Graham W Slack Research Topics

Disease

16	Neoplasms (Cancer) 10/2021 - 09/2012
15	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2024 - 10/2012
7	Lymphoma (Lymphomas) 06/2023 - 03/2013
6	Hodgkin Disease (Hodgkin's Disease) 11/2022 - 03/2014
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2021 - 03/2014
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 03/2014
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2022 - 01/2020
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 05/2017
2	Immunoglobulin G4-Related Disease 01/2018 - 04/2017
1	Plasmablastic Lymphoma 10/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 11/2021
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2021
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	Lymphangioma (Cavernous Lymphangioma) 06/2018
1	Chylous Ascites 06/2018
1	Cystic Lymphangioma (Hygroma) 06/2018
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2018
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2018
1	Rheumatic Diseases (Rheumatism) 01/2018
1	Leukopenia 08/2017
1	Anemia 08/2017
1	Thrombocytopenia (Thrombopenia) 08/2017
1	Neutropenia 08/2017
1	Leukemia 05/2017
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 04/2017
1	Eosinophilia 04/2017
1	Rare Diseases (Rare Disease) 04/2017
1	Lymphadenopathy 04/2017
1	Disease Progression 06/2015
1	Hepatitis C 05/2015

Drug/Important Bio-Agent (IBA)

18	Rituximab (Mabthera)FDA Link 10/2021 - 10/2012
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 09/2012
7	Vincristine (Oncovin)FDA LinkGeneric 01/2017 - 10/2012
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 10/2012
6	Prednisone (Sone)FDA LinkGeneric 01/2017 - 10/2012
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2013
3	Biomarkers (Surrogate Marker)IBA 06/2023 - 05/2017
3	Formaldehyde (Formol)FDA Link 10/2021 - 09/2015
3	ParaffinIBA 10/2021 - 09/2015
3	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021 - 09/2012
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 09/2012
3	Dacarbazine (DIC)FDA LinkGeneric 01/2021 - 09/2012
2	Immunoglobulins (Immunoglobulin)IBA 10/2018 - 04/2017
2	SteroidsIBA 06/2018 - 04/2017
2	Immunoglobulin G (IgG)IBA 01/2018 - 04/2017
2	Etoposide (VP 16)FDA LinkGeneric 08/2017 - 06/2015
2	Gemcitabine FDA Link 08/2017 - 01/2017
1	TNF Receptor-Associated Factor 3IBA 04/2024
1	SphingolipidsIBA 11/2021
1	MicroRNAs (MicroRNA)IBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	obinutuzumabIBA 10/2021
1	Monoclonal AntibodiesIBA 10/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	AntigensIBA 01/2020
1	ChromatinIBA 01/2019
1	Bendamustine Hydrochloride FDA Link 01/2019
1	hemoglobin Brisbane (HbGL)IBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2017
1	Lenalidomide (CC 5013)FDA Link 08/2017
1	Immunoglobulin E (IgE)IBA 04/2017
1	Guanosine Diphosphate (GDP)IBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	R-CHOP protocolIBA 10/2016
1	Indicators and Reagents (Reagents)IBA 09/2015
1	carboxyl radical (COO-)IBA 09/2015
1	Ifosfamide FDA LinkGeneric 06/2015
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2015
1	Methotrexate (Mexate)FDA LinkGeneric 06/2015
1	Antiviral Agents (Antivirals)IBA 05/2015
1	LigandsIBA 03/2014

Therapy/Procedure

8	Therapeutics 06/2023 - 03/2013
7	Drug Therapy (Chemotherapy) 11/2022 - 05/2015
2	Radiotherapy 01/2021 - 01/2021
1	Organ Transplantation 01/2020
1	Aftercare (After-Treatment) 05/2017
1	Salvage Therapy 01/2017
1	Treatment Delay 01/2016
1	Cell Transplantation 06/2015
1	Hematopoietic Stem Cell Transplantation 06/2015
1	Transplantation 06/2015
1	Splenectomy 05/2015
1	Complementary Therapies (Alternative Medicine) 12/2014